Temporal and spatial expression of preprotachykinin A mRNA in the developing filial mice brain after maternal administration of monosodium glutamate at a late stage of pregnancy

Neuroscience

Volumn 145, Issue 3, 2007, Pages 974-980

  Xu, L ^a   Zhao, Y ^a   Zhan, S Q ^a   Tang, X D ^b   Guo, Y ^a   Wang, H S ^a   Yang, C ^c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

development; excitotoxicity; fetal brain; monosodium l glutamate; mRNA; preprotachykinin A

Indexed keywords

DIGOXIGENIN; GLUTAMATE SODIUM; MESSENGER RNA; PREPROTACHYKININ; PREPROTACHYKININ A; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN TISSUE; CELL COUNT; CONTROLLED STUDY; EXCITOTOXICITY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN SITU HYBRIDIZATION; MEDIAN EMINENCE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PUTAMEN; THALAMUS MIDLINE NUCLEUS;

ANIMALS; BRAIN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU HYBRIDIZATION; MICE; MICE, INBRED STRAINS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN PRECURSORS; RNA, MESSENGER; SODIUM GLUTAMATE; TACHYKININS;

EID: 33947383045     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.12.029     Document Type: Article

References (49)

1. Aarts M.M., and Tymianski M. Novel treatment of excitotoxicity: targeted disruption of intracellular signaling from glutamate receptors. Biochem Pharmacol 66 (2003) 877-886
2. Akbarian S., Akbarian, Smith M.A., and Jones E.G. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res 699 (1995) 297-304
3. Ali M.M., Bawari M., Misra U.K., and Babu G.N. Locomotor and learning deficits in adult rats exposed to monosodium L-glutamate during early life. Neurosci Lett 284 (2000) 57-60
4. Angulo J.A., Williams A., Ledoux M., Watanable Y., and McEwen B.S. Elevation of striatal and accumbal preproenkephalin, preprotachykinin and preprodynorphin mRNA abundance subsequent to N-methyl-D-aspartate receptor blockade with MK-801. Mol Brain Res 29 (1995) 15-22
5. Balázs R., Hack N., and Jørgenson O.S. Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci Lett 87 (1988) 80-86
6. Brené S., Lindefors N., Friedman W.J., and Persson H. Preprotachykinin A mRNA expression in the rat brain during development. Dev Brain Res 57 (1990) 151-162
7. Brennenman D.E., Forsythe I.D., Nicole T., and Nelson P.G. N-methyl-D-aspartate receptors influence neuronal survival in developing spinal cord cultures. Dev Brain Res 51 (1990) 63-68
8. Brewer G.J., and Cotman C.W. NMDA receptor regulation of neuronal morphology in cultured hippocampus neurons. Neurosci Lett 99 (1989) 268-273
9. Cendes F., Andermann F., Carpenter S., and Zatorre R.J. Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in human. Ann Neurol 37 (1995) 123-126
10. Choi B.H., Hur E.M., Lee J.H., Jun D.J., and Kim K.T. Protein kinase C-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. J Cell Sci 119 (2006) 1329-1340
11. Choi D.W. Excitotoxic cell death. J Neurobiol 23 (1992) 1261-1276
12. Conti F., Fabri M., and Minelli A. Numerous SP-positive pyramidal neurons in cat neocortex are glutamate-positive. Brain Res 599 (1992) 140-143
13. Del Rio J., Soriano E., and Ferrer I. A transitory population of substance P-like immunoreactive neurones in the developing cerebral cortex of the mouse. Dev Brain Res 64 (1991) 205-211
14. Fogal B., Trettel J., Uliasz T.F., Levine E.S., and Hewett S.J. Changes in secondary glutamate release underlie the development regulation of excitotoxic neuronal cell death. Neuroscience 132 (2005) 929-942
15. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (1999), Academic Press, New York
16. González-Burgos I., Pérez-Vega M.I., and Beas-Zárate C. Neonatal exposure to monosodium glutamate induces cell death and dendritic hypotrophy in rat prefrontocortical pyramidal neurons. Neurosci Lett 297 (2001) 69-72
17. Hu H.J., Chen L.W., Yung K.K.L., and Chan Y.S. Differential expression of AMPA receptor subunits in substance P receptor-containing neurons of the caudate-putamen of rats. Neurosci Res 49 (2004) 281-288
18. Ikonomidou C., Mosinger J.L., Shahid S.K., Labruyere J., and Olney J.W. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-D-aspartate neurotoxicity. J Neurosci 9 (1989) 2809-2818
19. Jones E.G., DeFelipe J., Hendry S.H.C., and Maggio J.E. A study of tachykinin-immunoreactive neurons in monkey cerebral cortex. J Neurosci 8 (1988) 1206-1224
20. Kim H.S., Park C.H., Cha S.H., Lee J.H., Lee S., and Kim Y. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J 14 (2000) 1508-1517
21. Klingberg H., Brankačk J., and Klingberg F. Long-term effects on behaviour after postnatal treatment with monosodium-L-glutamate. Biomed Biochem Acta 46 (1987) 705-711
22. Kure S., Tominaga T., Yoshimoto T., Tada K., and Narisawa K. Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem Biophys Res Commun 179 (1991) 39-45
23. Lawlor B.A., and Davis K.L. Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?. Biol Psychiatry 15 (1992) 337-350
24. Lee Y.H., Fang K.M., Yang C.M., Hwang H.M., Chi C.T., and Tsai W. Kainic acid-induced neurotrophic activities in developing cortical neurons. J Neurochem 74 (2000) 2401-2411
25. Li Y.H., and Ku Y.H. Involvement of rat lateral septum-acetylcholine pressor system in central amygdaloid nucleus-emotional pressor circuit. Neurosci Lett 323 (2002) 60-64
26. Lipton S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. J Am Soc Exp Neurol Ther 1 (2004) 101-110
27. Mattson M.P., Pedersen W.A., Duan W., and Culmsee C. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's disease. Ann N Y Acad Sci 893 (1999) 154-175
28. McDonald J.W., and Johnston M.V. Pharmacology of N-methyl-D-aspartate-induced brain injury in an in vivo perinatal rat model. Synapse 6 (1990) 179-188
29. McDonald J.W., Silverstein F.S., and Johnston M.V. Neurotoxicity to N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 459 (1988) 200-203
30. Murphy T.H., and Baraban J.M. Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents. Dev Brain Res 57 (1990) 146-150
31. Nacher J., Alonso-Llosa G., Rosell D., and McEwen B. PSA-NCAM expression in the piriform cortex of the adult rat. Modulation by NMDA receptor antagonist administration. Brain Res 927 (2002) 111-121
32. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 258 (1992) 597-603
33. Nemeroff C.B., Konkol R.J., Bissette G., Youngblood W., Martin J.B., Brazeau P., Rone M.S., Prange Jr. A.J., Breese G.R., and Kizer J.S. Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): Evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. Endocrinology 101 (1977) 613-622
34. Noailles P.A.H., Villegas M., Ledoux M., Lucas L.R., McEwen B.S., and Angulo J.A. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol of scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain. Neurosci Lett 202 (1996) 165-168
35. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164 (1969) 719-721
36. Otsuka M., and Yoshioa K. Neurotransmitter function of mammalian tachykinins. Physiol Rev 73 (1993) 229-308
37. Pompi P., Severini R., Costa G., Massi M., Fattoretti P., and Bertoni-Freddari C. In situ hybridization analysis of preprotachykinin-A mRNA levels in young and old rats. Mol Brain Res 64 (1999) 132-136
38. Rothman S.M., and Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19 (1986) 105-111
39. Scatton B. The NMDA receptor complex. Fundam Clin Pharmacol 7 (1993) 389-400
40. Schelman W.R., Andres R.D., Sipe K.J., Kang E., and Weyhenmeyer J.A. Glutamate mediates cell death and increases the Bax to Bcl-2 ratio in a differentiated neuronal cell line. Mol Brain Res 128 (2004) 160-169
41. 2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A 102 (2005) 2602-2607
42. Varga V., Kekesi A., Juhasz G., and Kocsis B. Reduction of the extracellular level of glutamate in the median raphe nucleus associated with hippocampal theta activity in the anaesthetized rat. Neuroscience 84 (1998) 49-57
43. Xu L., Zhao Y., Zhan S.Q., Wang H.S., and Shi W.C. Expression of bax and bcl-2 in mouse offspring brain after maternal oral administration of monosodium glutamate. J Xi'an Med Univ 14 (2002) 38-42
44. Yamashita A., Shimizu K., and Hayashi M. Ontogeny of substance P-immunoreactive structures in the primate cerebral neocortex. Dev Brain Res 57 2 (1990) 197-207
45. Yang C., Zhao Y., Wang H.S., and Shi W.C. Effect of melatonin against glutamate-induced excitotoxicity on cultured cerebral cortical neurons. J Xi'an Med Univ 12 (2000) 101-103
46. Yang C., Zhao Y., Wang H.S., and Xu L. The cerebral cortical neuronal apoptosis glutamate-induced. J Xi'an Med Univ 22 (2001) 205-208
47. Yu L., Zhang Y., Ma R., Bao L., Fang J., and Yu T. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Eur Neuropsychopharmacol 16 (2006) 170-177
48. Yu T.X., Zhao Y., Shi W.C., Ma R.D., and Yu L.J. Effects of maternal oral administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Brain Res 747 (1997) 195-206
49. Zhang L., and Harlan R.E. Ontogeny of the distribution of tachykinins in rat cerebral cortex: immunocytochemistry and in situ hybridization histochemistry. Dev Brain Res 77 (1994) 23-36